Disease Management in Adolescents With Type 1 Diabetes
The Effect of the Education Program Prepared in Line With Transition Theory on Adaptation to Adolescence and Disease Management in Adolescents With Type 1 Diabetes: Randomized Controlled Study
1 other identifier
interventional
58
1 country
1
Brief Summary
Adolescence period; It is a transition period of rapid growth, development and maturation in biochemical, physical, social and spiritual terms, which lasts from the beginning of puberty to young adulthood. Adolescence is a predictable developmental transition period for the individual. They also encounter unpredictable situations (such as childhood illnesses). One of these conditions is Type 1 Diabetes Mellitus, which is the most common metabolic endocrine system disease in adolescents. Type 1 diabetes is an important health/disease transition in the life of a child and adolescent. Therefore, this study aimed to determine the effect of the "Adaptation to Adolescence and Type 1 Diabetes Management Training Programme", prepared in line with Meleis's Transition Theory, on the adolescent's developmental transition adaptation, self-efficacy for diabetes management and glycemic control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 30, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedJuly 31, 2024
July 1, 2024
2.1 years
January 30, 2024
July 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reynolds Adjustment Screening Inventory for Adolescents
Reynolds Adjustment Screening Inventory has four subscales. These; emotional distress (10 items), antisocial behavior (8 items), positive self (6 items related to self-confidence and socialization) and anger control problems (8 items). The Cronbach alpha value of the scale is stated as 0.91. The lowest score of the scale is 32 and the highest score is 165.
This scale was administered three times at beginning, 3rd and 6th months.
Secondary Outcomes (2)
Diabetes Management Self-Efficacy Scale in Adolescents with Type 1 Diabetes
This scale was administered three times at beginning, 3rd and 6th months.
Glycemic Control - Hemoglobin A1C
This scale was administered three times at beginning, 3rd and 6th months.
Study Arms (2)
Experimental group
EXPERIMENTALIn addition to the institution's routine T1DM training, the "Adjustment to Adolescence and Transition to Type 1 Diabetes Education Program" prepared in line with Meleis's Transition Theory was applied to adolescents online via the Microsoft Teams Program.
Control group
NO INTERVENTIONThe institution's routinely planned diabetes education was given by the pediatric diabetes education nurse.
Interventions
The content of the Training Program was created by researchers based on Transition Theory, in line with high-level research results and international guides. Then, the necessary arrangements were made by taking the opinions of 10 experts (child health and disease nursing faculty member, child and adolescent mental health specialist, child endocrinologist, child development specialist, nutrition and dietetics specialist, sports training specialist). The content was finalized in line with the comments received.
Eligibility Criteria
You may qualify if:
- Having been diagnosed with type 1 diabetes in the last 6 months
- HbA1c level \>7.5
You may not qualify if:
- presence of a diagnosis of intellectual disability, autism spectrum disorder and psychotic disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akdeniz Univercity
Antalya, 07100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ceren Calik
Akdeniz Univercity
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master of Science, specialist nurse
Study Record Dates
First Submitted
January 30, 2024
First Posted
February 7, 2024
Study Start
April 1, 2022
Primary Completion
April 30, 2024
Study Completion
April 30, 2024
Last Updated
July 31, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share